Literature DB >> 25636510

Capn4 promotes non-small cell lung cancer progression via upregulation of matrix metalloproteinase 2.

Jie Gu1, Feng-kai Xu, Guang-yin Zhao, Chun-lai Lu, Zong-wu Lin, Jian-yong Ding, Di Ge.   

Abstract

The expression of calpain small subunit 1 (Capn4) is correlated with the invasion of several types of tumors. However, the roles of Capn4 in non-small cell lung cancer (NSCLC) remain unclear. In this study, we found that the expression of Capn4 in NSCLC tissues was much higher than that in nontumorous samples. High levels of Capn4 expression were associated with lymph node metastasis and large tumor size in NSCLC patients. The 5-year overall survival rate in the Capn4(high) group was significantly lower than that in the Capn4(low) group. In multivariate analysis, Capn4 was identified as an independent prognostic factor for overall survival. Moreover, in an in vitro analysis, downregulation of Capn4 expression by siRNA suppressed the invasive potential of lung cancer cells. Finally, we demonstrated that Capn4 enhanced the invasion ability of lung cancer cells by upregulating the expression of matrix metalloproteinase 2. Our findings indicated that Capn4 may represent a potential therapeutic target and a novel prognostic marker of NSCLC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25636510     DOI: 10.1007/s12032-015-0500-7

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  27 in total

1.  Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division.

Authors:  J S Arthur; J S Elce; C Hegadorn; K Williams; P A Greer
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 2.  Regulating cell migration: calpains make the cut.

Authors:  Santos J Franco; Anna Huttenlocher
Journal:  J Cell Sci       Date:  2005-09-01       Impact factor: 5.285

Review 3.  Matrix metalloproteinases in cancer: prognostic markers and targets for therapy (review).

Authors:  M J Duffy; K McCarthy
Journal:  Int J Oncol       Date:  1998-06       Impact factor: 5.650

Review 4.  The role of matrix metalloproteinase 2 on the survival of patients with non-small cell lung cancer: a systematic review with meta-analysis.

Authors:  Qian Qian; Qian Wang; Ping Zhan; Ling Peng; Shu-Zhen Wei; Yi Shi; Yong Song
Journal:  Cancer Invest       Date:  2010-07       Impact factor: 2.176

Review 5.  The calpain system and cancer.

Authors:  Sarah J Storr; Neil O Carragher; Margaret C Frame; Tim Parr; Stewart G Martin
Journal:  Nat Rev Cancer       Date:  2011-05       Impact factor: 60.716

6.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

7.  Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts.

Authors:  N Dourdin; A K Bhatt; P Dutt; P A Greer; J S Arthur; J S Elce; A Huttenlocher
Journal:  J Biol Chem       Date:  2001-10-15       Impact factor: 5.157

8.  Capn4 mRNA level is correlated with tumour progression and clinical outcome in clear cell renal cell carcinoma.

Authors:  Qianfeng Zhuang; Xi Qian; Yunjie Cao; Min Fan; Xianlin Xu; Xiaozhou He
Journal:  J Int Med Res       Date:  2014-02-10       Impact factor: 1.671

9.  Calpain-2 as a target for limiting prostate cancer invasion.

Authors:  Asmaa Mamoune; Jian-Hua Luo; Douglas A Lauffenburger; Alan Wells
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

10.  Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma.

Authors:  Chi Zhang; Dou-Sheng Bai; Xiao-Yong Huang; Guo-Ming Shi; Ai-Wu Ke; Liu-Xiao Yang; Xin-Rong Yang; Jian Zhou; Jia Fan
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

View more
  14 in total

1.  A detrimental mutation on USP40 unlocks the tumorigenesis in a rare case of lung cancer.

Authors:  Zhi-Hong Xu; Hui Wang; Xiao-Yang Ji; Fei-Xu Zhang; Bei-Li Gao; Jia-An Hu; Jing Zheng
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

2.  Comprehensive analysis of prognostic value and immune infiltration of calpains in pancreatic cancer.

Authors:  Chuan Lan; Haoyou Tang; Sheng Liu; Lin Ma; Jianshui Li; Xi Wang; Yifu Hou
Journal:  J Gastrointest Oncol       Date:  2021-12

3.  Copper-based metal-organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade.

Authors:  Sijie Wang; Na Yin; Yongjuan Li; Tingting Xiang; Wenxiao Jiang; Xiu Zhao; Wei Liu; Zhenzhong Zhang; Jinjin Shi; Kaixiang Zhang; Xingming Guo; Pilei Si; Junjie Liu
Journal:  J Nanobiotechnology       Date:  2022-07-06       Impact factor: 9.429

4.  MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.

Authors:  Baoyuan Shi; Yandan Wang; Fengfang Yin
Journal:  Cancer Biol Ther       Date:  2017-08-31       Impact factor: 4.742

5.  Gene/protein expression of CAPN1/2-CAST system members is associated with ERK1/2 kinases activity as well as progression and clinical outcome in human laryngeal cancer.

Authors:  Katarzyna Starska; Ewa Forma; Paweł Jóźwiak; Iwona Lewy-Trenda; Marian Danilewicz; Olga Stasikowska-Kanicka; Michał Skóra; Katarzyna Kolary; Jakub Miazga; Anna Krześlak; Magdalena Bryś
Journal:  Tumour Biol       Date:  2016-07-25

6.  miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4.

Authors:  Haili Hu; Guanghui Wang; Congying Li
Journal:  Onco Targets Ther       Date:  2017-05-23       Impact factor: 4.147

7.  Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis.

Authors:  S Elizabeth Franks; Ritesh Briah; Robert A Jones; Roger A Moorehead
Journal:  Oncotarget       Date:  2016-01-19

8.  Elevated Expression of Calpain-4 Predicts Poor Prognosis in Patients with Gastric Cancer after Gastrectomy.

Authors:  Peike Peng; Lingqiang Min; Shushu Song; Junjie Zhao; Lili Li; Caiting Yang; Miaomiao Shao; Mingming Zhang; Hao Wu; Jie Zhang; Can Li; Xuefei Wang; Hongshan Wang; Jing Qin; Yuanyuan Ruan; Jianxin Gu
Journal:  Int J Mol Sci       Date:  2016-09-27       Impact factor: 5.923

9.  Capn4 overexpression indicates poor prognosis of ovarian cancer patients.

Authors:  Ming-Fang Yang; Yuan-Lei Lou; Si-Sun Liu; Shan-Shan Wang; Chun-Hua Yin; Xiao-Hua Cheng; Ou-Ping Huang
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

10.  CAPN1 promotes malignant behavior and erlotinib resistance mediated by phosphorylation of c-Met and PIK3R2 via degrading PTPN1 in lung adenocarcinoma.

Authors:  Yichuan Chen; Jingqun Tang; Ting Lu; Fang Liu
Journal:  Thorac Cancer       Date:  2020-05-12       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.